QDEL
QuidelOrtho Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$14.07
+1.01%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
16.3x
EV/EBITDA
−7.9x
Market Cap
$964.92M
MomentumView details →
1D Return
+1.01%
YTD Return
−50.91%
RSI (14)
43.7
ValuationView details →
P/E (Fwd)
16.3x
EV/EBITDA
−7.9x
Market Cap
$964.92M
RSI (14)
43.7
MomentumView details →
1D Return
+1.01%
YTD Return
−50.91%
SummaryUpdated Jun 1, 2026
QuidelOrtho Corporation (NASDAQ:QDEL) is a leading diagnostic testing company formed through the 2022 merger of Quidel Corporation and Ortho Clinical Diagnostics. Founded originally as Quidel in 1979, the company has evolved into a comprehensive diagnostics provider serving healthcare facilities worldwide. The company went public in 1991 and is headquartered in San Diego, California. QuidelOrtho operates across the full spectrum of diagnostic testing, from point-of-care rapid tests to sophisticated laboratory instruments, serving hospitals, clinical laboratories, blood banks, and physician offices globally.
Similar companies
Latest newsMore news →
QuidelOrtho cut its 2026 outlook, citing deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.18d agoQuidelOrtho Corporation reported second quarter 2026 financial results with total revenue of $631 million, up 3% as reported and 2% in constant currency, driven by Labs and Point of Care growth.29d agoQuidelOrtho plans to sell its testing unit for $1.5 billion.69d ago